Prospect Biosystems designs and manufactures its Edge™ 200 Separation System, GradiSpec™ reagent kits, and EDGE*TEST™ biomarker evaluation platform. The company also provides biomarker evaluation and extensive proteomics services.
Edge 200 Separation System – A biomarker discovery platform for:
- Biomarker discovery
- Analytical Proteomics
- Drug Discovery and Development
- Disease Diagnostics and Management
EDGE*TEST– Rapid biomarker evaluation and validation platform for:
Biomarker and Subcellular Fractionation Services
- Surgical pathology
- Clinical diagnostics
– Expand your research capacity and increase your information
Prospect…."a prediction of the course of a disease"